Evoke Wealth, LLC Cyma Bay Therapeutics, Inc. Transaction History

Evoke Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.23 - $6.55 $1,408 - $2,181	-333 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $1,908 - $3,006	333 New	333 $2,000
Q2 2020 Aug 10, 2020	SELL	$1.41 - $4.25 $1,431 - $4,313	-1,015 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$1.33 - $5.93 $1,349 - $6,018	1,015 New	1,015 $1.99 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.